Gestational Diabetes Risk During Treatment With Antipsychotic Medications

Dr. Newcomer has received grant support from NIH and Otsuka; he has served as a consultant to Alkermes, Indivior, Otsuka, and Sunovion; and he has served on the data safety monitoring board for Amgen. Dr. Nicol receives or has received research support from the Center for Brain Research in Mood Disorders at Washington University, NIMH, Otsuka America, and the Sidney R. Baer, Jr., Foundation for investigator-initiated research studies; and she has served as principle investigator or co-investigator on industry-sponsored clinical trials funded by Alkermes, Shire, and Takeda. Dr. Freedman has reviewed this editorial and found no evidence of influence from these relationships.